Metformin Lawsuit: Claim Deadline Has Passed

What is the Metformin Lawsuit about?

A $5.55 million settlement resolves claims that Teva, Actavis, Granules, and Heritage falsely marketed their generic metformin as equivalent to brand-name Glucophage while it was allegedly contaminated with NDMA, a probable human carcinogen. If you paid for one of these generic metformin drugs between July 20, 2015 and June 2, 2020, you may be entitled to a payment from the settlement fund.

Who qualifies for the Metformin Lawsuit?

You may qualify for the Metformin Lawsuit if you meet the eligibility requirements below. Eligibility is finally determined by the settlement administrator, not by Payout.

• Paid for a generic metformin-containing drug between July 20, 2015 and June 2, 2020
• The medication was made, distributed, or sold by Teva, Actavis, Granules, or Heritage/Avet
• It was purchased for personal or household use
• Open to eligible U.S. purchasers

Frequently asked questions

Before you file

If this is your first claim, how to claim a class action settlement walks through the process end to end, and what class action settlements actually pay per person explains how the amount is decided before you spend time on the form. Many cases need no receipts at all — see settlements with no proof of purchase.